IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Biomolecules and Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on June 27, 2025

Impact Score

2024-2025

3.46

h-Index

2024-2025

 61

Rank

2024-2025

 4429

SJR

2024-2025

 1.054

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Biomolecules and Therapeutics
Abbreviation Biomol. Ther.
Publication Type Journal
Subject Area, Categories, Scope Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2)
h-index 61
Overall Rank/Ranking 4429
SCImago Journal Rank (SJR) 1.054
Impact Score 3.46
Publisher Korean Society of Applied Pharmacology
Country South Korea
ISSN 19769148, 20054483
Best Quartile Q1
Coverage History 2008-2025




About Biomolecules and Therapeutics


Biomolecules and Therapeutics is a journal covering the technologies/fields/categories related to Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2). It is published by Korean Society of Applied Pharmacology. The overall rank of Biomolecules and Therapeutics is 4429. According to SCImago Journal Rank (SJR), this journal is ranked 1.054. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 61. The best quartile for this journal is Q1.

The ISSN of Biomolecules and Therapeutics journal is 19769148, 20054483. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Biomolecules and Therapeutics is cited by a total of 785 articles during the last 3 years (Preceding 2024).


Biomolecules and Therapeutics Impact IF 2024-2025


The Impact IF 2024 of Biomolecules and Therapeutics is 3.46, which is computed in 2025 as per its definition. Biomolecules and Therapeutics IF is increased by a factor of 0.23 and approximate percentage change is 7.12% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Biomolecules and Therapeutics Impact IF 2025 Prediction


Impact IF 2024 of Biomolecules and Therapeutics is 3.46. If the same upward trend persists, Impact IF may rise in 2025 as well.


Impact IF Trend


Year wise Impact IF of Biomolecules and Therapeutics. Based on Scopus data.


Year Impact IF
2025/2026 Coming Soon
2024 3.46
2023 3.23
2022 4.04
2021 4.35
2020 4.45
2019 3.44
2018 3.14
2017 2.75
2016 2.99
2015 2.76
2014 1.93

Biomolecules and Therapeutics h-index


  Table Setting

Biomolecules and Therapeutics has an h-index of 61. It means 61 articles of this journal have more than 61 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Biomolecules and Therapeutics ISSN


The ISSN of Biomolecules and Therapeutics is 19769148, 20054483. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Biomolecules and Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Biomolecules and Therapeutics is 4429. According to SCImago Journal Rank (SJR), this journal is ranked 1.054. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Biomolecules and Therapeutics by Year


Year SJR
2025/2026 Coming Soon
2024 1.054
2023 0.843
2022 0.882
2021 0.965
2020 0.977
2019 0.920
2018 0.939
2017 0.946
2016 0.993
2015 0.868
2014 0.441

Ranking of Biomolecules and Therapeutics by Year


Year Ranking
2025/2026 Coming Soon
2024 4429
2023 5736
2022 5127
2021 4316
2020 4520
2019 4885
2018 4741
2017 4704
2016 4468
2015 5316
2014 9906

Biomolecules and Therapeutics Publisher


Table Setting

Biomolecules and Therapeutics is published by Korean Society of Applied Pharmacology. It's publishing house is located in South Korea. Coverage history of this journal is as following: 2008-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Biomolecules and Therapeutics is Biomol. Ther.. This abbreviation ('Biomol. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Biomolecules and Therapeutics


If your research field is/are related to Drug Discovery (Q1); Pharmacology (Q1); Biochemistry (Q2); Molecular Medicine (Q2), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Biomolecules and Therapeutics?

Biomolecules and Therapeutics latest impact IF is 3.46. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 4.45 (2020) and 1.93 (2014), respectively, in the last 11 years. Moreover, its average IS is 3.32 in the previous 11 years.


What's the SCImago Journal Rank (SJR) of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics has an SJR (SCImago Journal Rank) of 1.054, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.054 in 2024 and the lowest being 0.441 in 2014. Furthermore, the average SJR of the Biomolecules and Therapeutics over the previous 11-year period stands at 3.32.


What's the latest h-index of the Biomolecules and Therapeutics?

The latest h-index of the Biomolecules and Therapeutics is 61.


Who's the publisher of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is published by the Korean Society of Applied Pharmacology, with its country of publication being the South Korea.


What's the current ranking of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is currently ranked 4429 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 4316 in 2021 and its lowest position of 9906 in 2014.


What's the abbreviation or short name for the Biomolecules and Therapeutics?

The standard ISO4 abbreviation for the Biomolecules and Therapeutics is Biomol. Ther..


Is the "Biomolecules and Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Biomolecules and Therapeutics is classified as a journal that the Korean Society of Applied Pharmacology publishes.


What's the scope or major areas of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics encompasses the following areas:

  • Drug Discovery
  • Pharmacology
  • Biochemistry
  • Molecular Medicine

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 19769148, 20054483.


What's the best quartile of the Biomolecules and Therapeutics?

The best quartile for the Biomolecules and Therapeutics is Q1 (2024).


What's the coverage history of the Biomolecules and Therapeutics?

The Biomolecules and Therapeutics coverage history can be summarized as follows: 2008-2025.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Journal of Academic Ethics journal 8704 Springer Netherlands 34 4.04
Revue Francophone des Laboratoires (discontinued) journal 23244 Elsevier Masson s.r.l. 8 0.00
Clinical Medicine and Research journal 14921 Marshfield Clinic 64 1.25
CESifo Economic Studies journal 17776 Oxford University Press 36 0.89
Journal of Business Finance and Accounting journal 3244 Wiley-Blackwell Publishing Ltd 96 3.34
Discourse journal 7536 Routledge 70 2.75
World Englishes journal 7267 Wiley-Blackwell 68 2.38
International Journal of Research and Method in Education journal 6367 Taylor and Francis Ltd. 41 3.31
Transnational Corporations journal 13970 UNCTAD United Nations Conference on Trade and Development 30 1.63
European Surgery - Acta Chirurgica Austriaca journal 18136 Springer Medizin 25 0.68

Check complete list




Year wise Impact Score (IS) of Biomolecules and Therapeutics

Impact Score Table

Year Impact Score (IS)
2025/2026 Coming Soon
2024 3.46
2023 3.23
2022 4.04
2021 4.35
2020 4.45
2019 3.44
2018 3.14
2017 2.75
2016 2.99
2015 2.76
2014 1.93



Top Journals/Conferences in Drug Discovery

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Protein and Cell
Oxford University Press | United Kingdom

Molecular Therapy
Cell Press | United States

Medicinal Research Reviews
John Wiley & Sons Inc. | United States

Cell Chemical Biology
Elsevier Ltd | United Kingdom

MedComm
John Wiley and Sons Inc | United States

Natural Product Reports
Royal Society of Chemistry | United Kingdom

Emerging Microbes and Infections
Taylor and Francis Ltd. | United Kingdom

Molecular Therapy - Nucleic Acids
Cell Press | United States

Archives of Pharmacal Research
Pharmaceutical Society of Korea | South Korea

See All

Top Journals/Conferences in Pharmacology

Nature Reviews Drug Discovery
Nature Research | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Drug Resistance Updates
Churchill Livingstone | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Annual Review of Pharmacology and Toxicology
Annual Reviews Inc. | United States

Molecular Therapy
Cell Press | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Trends in Pharmacological Sciences
Elsevier Ltd | United Kingdom

Acta Pharmaceutica Sinica B
Chinese Academy of Medical Sciences | China

Theranostics
Ivyspring International Publisher | Australia

See All

Top Journals/Conferences in Biochemistry

Cell
Elsevier B.V. | United States

Nature Medicine
Nature Research | United Kingdom

Nature Methods
Nature Research | United Kingdom

Nature Reviews Methods Primers
Springer Nature | United Kingdom

Nature Catalysis
Nature Publishing Group | United States

Annual Review of Biochemistry
Annual Reviews Inc. | United States

Annual Review of Medicine
Annual Reviews Inc. | United States

Cell Genomics
Cell Press | United States

Chem
Elsevier Inc. | United States

Nature Protocols
Springer Nature | United Kingdom

See All

Top Journals/Conferences in Molecular Medicine

Nature Biotechnology
Nature Research | United Kingdom

Cell Stem Cell
Cell Press | United States

Molecular Cancer
BioMed Central Ltd | United Kingdom

Pharmacological Reviews
Elsevier Inc. | United States

Genome Medicine
BioMed Central Ltd | United Kingdom

Journal for ImmunoTherapy of Cancer
BMJ Publishing Group | United Kingdom

Molecular Therapy
Cell Press | United States

Experimental and Molecular Medicine
Springer Nature | United Kingdom

Trends in Molecular Medicine
Elsevier Ltd | United Kingdom

EMBO Molecular Medicine
Springer Science and Business Media Deutschland GmbH | United Kingdom

See All